Vaibhav Sahai, MBBS, MS
University of Michigan
3
3
1
N/A
0
2
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Midhun Malla, MD, MS
University of Alabama at Birmingham
Shared therapeutic areas:
Worked with same sponsors:
Ghassan Abou-Alfa, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Ming Kuang, PhD
First Affiliated Hospital, Sun Yat-Sen University
Shared therapeutic areas:
Do-Youn Oh, MD, PhD
Seoul National University Hospital
Shared therapeutic areas:
Andrew X. Zhu, MD
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Feng Shen
Eastern Hepatobiliary Surgery Hospital
Shared therapeutic areas:
Toshimitsu Tokimoto
Astrazeneca KK
Shared therapeutic areas:
Antoine ITALIANO, MD, PhD
Institut Bergonié
Shared therapeutic areas:
Brennan Spiegel, MD, MSHS
Cedars-Sinai Medical Center
Shared therapeutic areas:
Worked with same sponsors:
Francesco Perrone, M.D., Ph.D
National Cancer Institute Naples, Italy; Director Clinical Trials Unit
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy
Phase Ib/II Trial of Nal-Irinotecan and Nivolumab as Second-Line Treatment in Patients With Advanced Biliary Tract Cancer
Zolbetuximab With mFOLFOX6 or CAPOX in Claudin 18.2 Overexpressed Advanced or Metastatic Biliary Tract Cancers
All 3 trials loaded